Our speakers

Dr. Glenn is a pioneer in vaccine delivery and adjuvants, and has brought several products from concept into clinical development, such as the travelers' diarrhea vaccine patch and an adjuvant patch for a pandemic influenza vaccine, developed under U.S. government contracts. He provided the scientific and technical leadership that led to the...

Dr. Gordon has over 25 years experience in the vaccine industry, developing both bacterial and viral vaccine products and companies. He is the inventor and developer of the first bacterial conjugate vaccine to receive FDA and European approval.  He is currently Director for Neglected Infectious Diseases in the Global Health Program at the Bill...

Teshome Mebatsion DVM, Ph.D. in Virology, University of Giessen, Germany. Joined Merial in February 2009 and leads the Vector Vaccine Research program. Prior to this, worked for 10 years at Intervet, now MSD (5 years in The Netherlands and 5 years in Delaware, USA). Extensive experience in designing and developing recombinant vaccines.  Author...

Marcelo Paniago is a veterinarian graduated in Brazil and he has worked in the poultry sector for over 27 years. He started his career in a Chicken Genetic Improvement Program at Universidade Federal de Viçosa/FINEP. After obtaining the degree of Master in Science (MSc) in Preventive Veterinary Medicine, he joined the Universidade...

Gregory A. Poland, M.D., is the director of Mayo Clinic’s Vaccine Research Group — a state-of-the-art research group and laboratory that investigates issues surrounding vaccine response and novel vaccines important to public health. Dr. Poland holds the academic rank of professor of medicine and infectious diseases and molecular pharmacology and...

Dr. Andrew Potter is a graduate of Carleton University (Canada) and the University of Otago (New Zealand) and has worked at the Vaccine and Infectious Disease Organization, University of Saskatchewan, for the past 27 years serving as a research scientist, Associate Director (Research) and more recently, Director.  His primary research interests...

Byron’s career focus has been predominantly regulatory veterinary medicine. He has had extensive experience with national programs both related to food safety and veterinary biological products.Currently as the Director- Policy, Evaluation & Licensing at the USDA, he manages the national program for licensing review and laboratory evaluations...

Dr Jerald C. Sadoff is currently the Head of Early Development of the Crucell Vaccine Institute which is the Center of Excellence for Vaccine Development for Johnson & Johnson Companies Worldwide. Dr. Sadoff has spent his entire career developing vaccines against a large number of bacterial, viral and parasitic diseases, 11 of which have been...

Samuel Thevasagayam, deputy director, leads the Livestock initiative within Agriculture Development. He oversees implementation of foundation’s strategy in animal health, livestock genetics and livestock production & marketsPrior to joining the foundation in 2012, Sam spent significant time in the pharmaceutical Industry, where he held various ...

Michael Leads the Sanofi Pasteur Vaccination Policy team that is responsible for the interface between Sanofi Pasteur and Global and Regional Governmental and Non-Governmental Public Health organisations involved in immunisation Policy, Funding, Financing and, Implementation, Advocacy and issue resolution. He recently completed his term as chair ...